Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CEBPA antibody (AA 1-124)

CEBPA Reactivity: Human WB, ELISA, IHC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7147076
  • Target See all CEBPA Antibodies
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Binding Specificity
    • 20
    • 14
    • 12
    • 9
    • 9
    • 8
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-124
    Reactivity
    • 100
    • 81
    • 72
    • 8
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    Human
    Host
    • 104
    • 3
    • 1
    • 1
    Rabbit
    Clonality
    • 98
    • 11
    Polyclonal
    Conjugate
    • 46
    • 9
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This CEBPA antibody is un-conjugated
    Application
    • 68
    • 40
    • 19
    • 16
    • 15
    • 15
    • 10
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human CCAAT/enhancer-binding protein alpha protein (1-124AA)
    Isotype
    IgG
    Top Product
    Discover our top product CEBPA Primary Antibody
  • Application Notes
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CEBPA (CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
    Alternative Name
    CEBPA (CEBPA Products)
    Synonyms
    C/EBP-alpha antibody, CEBP antibody, C/ebpalpha antibody, CBF-A antibody, Cebp antibody, DBPCEP antibody, c/ebpa antibody, cb1062 antibody, wu:fj20f03 antibody, C/EBP antibody, C/EBPalpha antibody, xC/EBP antibody, cC/EBP antibody, C/EBP alpha antibody, CCAAT/enhancer binding protein alpha antibody, CCAAT/enhancer binding protein (C/EBP), alpha antibody, CCAAT/enhancer binding protein alpha L homeolog antibody, CEBPA antibody, Cebpa antibody, cebpa antibody, cebpa.L antibody
    Background

    Background: Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5\\\'-T[TG]NNGNAA[TG]-3\\\' acting as an activator on distinct target genes (PubMed:11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Downregulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed:14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity).

    Aliases: Apoptotic cysteine protease antibody, Apoptotic protease Mch 5 antibody, C/EBP alpha antibody, C/ebpalpha antibody, CAP4 antibody, Caspase 8 precursor antibody, CBF-A antibody, CCAAT Enhancer Binding Protein alpha antibody, CCAAT/enhancer binding protein (C/EBP), alpha antibody, CCAAT/enhancer-binding protein alpha antibody, CEBP antibody, CEBP A antibody, CEBP alpha antibody, Cebpa antibody, CEBPA_HUMAN antibody, FADD homologous ICE/CED 3 like protease antibody, FADD like ICE antibody, FLICE antibody, ICE like apoptotic protease 5 antibody, ICE8 antibody, MACH antibody, MCH5 antibody, MORT1 associated CED 3 homolog antibody

    UniProt
    P49715
    Pathways
    Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
You are here: